AP2005003294A0 - Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome - Google Patents

Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Info

Publication number
AP2005003294A0
AP2005003294A0 AP2005003294A AP2005003294A AP2005003294A0 AP 2005003294 A0 AP2005003294 A0 AP 2005003294A0 AP 2005003294 A AP2005003294 A AP 2005003294A AP 2005003294 A AP2005003294 A AP 2005003294A AP 2005003294 A0 AP2005003294 A0 AP 2005003294A0
Authority
AP
ARIPO
Prior art keywords
prevention
treatment
acquired immunodeficiency
immunodeficiency syndrome
synergistic compositions
Prior art date
Application number
AP2005003294A
Other languages
English (en)
Inventor
Sek Fung Fung
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of AP2005003294A0 publication Critical patent/AP2005003294A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AP2005003294A 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome AP2005003294A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41406202P 2002-09-27 2002-09-27
PCT/US2003/030538 WO2004028473A2 (fr) 2002-09-27 2003-09-26 Compositions synergetiques pour la prevention et le traitement du syndrome d'immunodeficience acquise

Publications (1)

Publication Number Publication Date
AP2005003294A0 true AP2005003294A0 (en) 2005-06-30

Family

ID=32043337

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003294A AP2005003294A0 (en) 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Country Status (11)

Country Link
US (1) US20060121480A1 (fr)
EP (1) EP1543166A4 (fr)
JP (1) JP2006503849A (fr)
CN (3) CN100341573C (fr)
AP (1) AP2005003294A0 (fr)
AU (1) AU2003299085B2 (fr)
BR (1) BR0314711A (fr)
CA (1) CA2498483A1 (fr)
MX (1) MXPA05002851A (fr)
WO (1) WO2004028473A2 (fr)
ZA (1) ZA200502464B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE295370T1 (de) 2001-05-31 2005-05-15 Conjuchem Inc Langwirkende fusionspeptid-inhibitoren für hiv- infektion
EP1747233A4 (fr) * 2004-05-06 2007-04-25 Composes pour cible virale specifique
EP2054086A1 (fr) * 2006-08-17 2009-05-06 F. Hoffmann-Roche AG Conjugué d'un anticorps dirigé contre le ccr5 et peptide antifusiogène
TW200817438A (en) * 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
CL2008002092A1 (es) * 2007-07-20 2009-05-29 Hoffmann La Roche Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
RU2517084C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Способ и средство для ингибирования продукции или усиления элиминации белка р24
CN106139150B (zh) * 2015-04-10 2019-10-08 复旦大学 一种艾滋病治疗性疫苗组合物及其应用
EA035332B1 (ru) * 2015-04-24 2020-05-28 ВАЙВ ХЕЛТКЕР ЮКей (№5) ЛИМИТЕД Полипептиды, нацеленные на слияние вич

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007878A1 (fr) * 1990-10-26 1992-05-14 The Public Health Research Institute Of The City Of New York, Inc. Neutralisation d'anticorps monoclonaux humains specifiques contre la boucle v3 et le site de liaison cd-4 de hiv-1 gp120
AU662891B2 (en) * 1990-11-27 1995-09-21 Biogen Idec Ma Inc. Anti CD-4 antibodies blocking HIV-induced syncytia
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US5817767A (en) * 1993-02-24 1998-10-06 Progenics Pharmaceuticals, Inc. Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
AU723537B2 (en) * 1995-06-07 2000-08-31 Trimeris Inc. The treatment of HIV and other viral infections using combinatorial therapy
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody

Also Published As

Publication number Publication date
WO2004028473A2 (fr) 2004-04-08
HK1082923A1 (en) 2006-06-23
EP1543166A4 (fr) 2009-10-28
JP2006503849A (ja) 2006-02-02
MXPA05002851A (es) 2005-09-08
CN101152574A (zh) 2008-04-02
AU2003299085B2 (en) 2008-04-10
CN101152573A (zh) 2008-04-02
CN100341573C (zh) 2007-10-10
CA2498483A1 (fr) 2004-04-08
AU2003299085A1 (en) 2004-04-19
ZA200502464B (en) 2005-11-01
WO2004028473A3 (fr) 2004-12-09
EP1543166A2 (fr) 2005-06-22
US20060121480A1 (en) 2006-06-08
BR0314711A (pt) 2005-07-26
CN1685064A (zh) 2005-10-19

Similar Documents

Publication Publication Date Title
AU2003205737A1 (en) Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
IL183537A0 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
EP1628530B8 (fr) Procedes et compositions pour la prevention et le traitement de la sepsie
IL162838A0 (en) Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
EP1578437A4 (fr) Compositions et procedes de prevention et reduction de l'hypoglycemie induite par l'insuline
EG23626A (en) Synergistic seed treatment compositions
HRP20130602T1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
EP1476471A4 (fr) Aliments fonctionnels pour le traitement, la protection et la restauration des tissus conjonctifs
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
IL171972A0 (en) Compositions and methods for treatment of severe acute respiratory syndrome(sars)
HUP0400609A3 (en) Wet-skin treatment compositions
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
AP2005003294A0 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
IL161091A0 (en) Compositions for the treatment and prevention of plant pathogens
MXPA04001230A (es) Uso de inhibidores de il-18 en desordenes de hipersensibilidad.
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1305017A4 (fr) Procedes et compositions pour la prevention et le traitement du syndrome x
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
GB0313630D0 (en) Compositions for the enhanced treatment of depression
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases